Posterior reversible encephalopathy syndrome and anti-angiogenic agents: A case report

Neuro-Ophthalmology

Volumn 35, Issue 1, 2011, Pages 32-37

  Dos Reis Simões Da Silva, Filipe Manuel ^a   Burgos Pêgo, Peter Mike ^a   Henriques Vendrell, Maria Cristina ^a   De Azevedo Batalha Ferreira Dos Santos Farias, Maria João ^a   Ribeiro Timóteo, Ângela Cátia ^a   Martins Da Costa, Maria Cristina ^a   Monteiro Barbosa Moreira Cravo, Isabel Maria ^a   Ribeiro Gomes, Fernando Manuel ^a  

^a HOSPITAL PROF DOUTOR FERNANDO FONSECA   (Portugal)

Author keywords

bevacizumab; cortical blindness; posterior reversible encephalopathy syndrome; sunitinib; vasogenic oedema

Indexed keywords

AMLODIPINE; ANGIOGENESIS INHIBITOR; CAPTOPRIL; DOMPERIDONE; FUROSEMIDE; IMATINIB; OMEPRAZOLE; SUNITINIB;

ADULT; ARTICLE; BRAIN EDEMA; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; CONTROLLED STUDY; EYE EXAMINATION; GASTROINTESTINAL STROMAL TUMOR; HEADACHE; HUMAN; HYPERTENSIVE CRISIS; IMAGE ANALYSIS; LIVER METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NEUROIMAGING; PERCEPTION; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

EID: 79952058050     PISSN: 01658107     EISSN: 1744506X     Source Type: Journal    
DOI: 10.3109/01658107.2010.539763     Document Type: Article

References (30)

1. Norden AD, Batchelor TT. Reversible posterior leukoencephalopathy syndrome. Onkologie 2007;30:90-91. (Pubitemid 46384535)
2. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500. (Pubitemid 26067737)
3. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. Am J Neuroradiol 2008;29:1036-1042. (Pubitemid 351954863)
4. McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, Teksam M. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. Am J Roentgenol 2007;189:904-912. (Pubitemid 47485623)
5. Servillo G, Bifulco F, De Robertis E, Piazza O, Striano P, Tortora F, Striano S, Tufano R. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 2007;33:230-236. (Pubitemid 46221227)
6. Lamy C, Oppenheim C, Méder JF, Mas JL. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004;14:89-96. (Pubitemid 38391815)
7. Pula JH, Eggenberger E. Posterior reversible encephalopathy syndrome. Curr Opin Ophthalmol 2008;19:479-484.
8. Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 2005;35:83-90. (Pubitemid 40343439)
9. Leroux G, Sellam J, Costedoat-Chalumeau N, Le Thi Huong D, Combes A, Tieulié N, Haroche J, Amoura Z, Nieszkowska A, Chastre J, Dormont D, Piette JC. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 2008;17:139-147. (Pubitemid 351346449)
10. Zhang YX, Liu JR, Ding MP, Huang J, Zhang M, Jansen O, Deuschl G, Eschenfelder CC. Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis. Intern Med 2008;47:867-875. (Pubitemid 351936209)
11. Finsterer J, Stollberger C, Ostermann E, Zuntner G, Huber J, Tscherney R. Recurrent posterior reversible encephalopathy syndrome in mitochondrial disorder. Blood Press 2009;12:1-4.
12. Kahana A, Rowley HA, Weinstein JM. Cortical blindness: clinical and radiologic findings in reversible posterior leukoencephalopathy syndrome: case report and review of the literature. Ophthalmology 2005;112:e7-e11. (Pubitemid 40202577)
13. Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. Am J Neuroradiol 2008;29:1043-1049. (Pubitemid 351954864)
14. Nguyen-Lam J, Kiernan MC. Acute cortical blindness due to posterior reversible encephalopathy. J Clin Neurosci 2008;15:1182-1185.
15. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008;65:205-210. (Pubitemid 351240781)
16. Chen TY, Lee HJ, Wu TC, Tsui YK. MR imaging findings of medulla oblongata involvement in posterior reversible encephalopathy syndrome secondary to hypertension. Am J Neuroradiol 2009;30:755-757.
17. Kollmannsberger C, Soulieres D, Wong R, Scalera A, Gaspo R, Bjarnason G. Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects. Can Urol Assoc J 2007;1(2 Suppl):S41-S54.
18. Izzedine H, Ederhy S, Goldwasser F, Soria JC, Milano G, Cohen A, Khayat D, Spano JP. Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol 2009;20:807-815.
19. Martin G, Bellido L, Cruz, JJ. Reversible posterior leukoencephalopathy syndrome induced by sunitinib. J Clin Oncol 2007;25:3559-3559.
20. Medioni J, Cojocarasu O, Banu E, Queudeville AC, Halimi P, Oudard S. Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient. Target Oncol 2007;2:193-195.
21. Cumurciuc R, Martinez-Almoyna L, Henry C, Husson H, de Broucker T. Posterior reversible encephalopathy syndrome during sunitinib therapy. Rev Neurol (Paris) 2008;164:605-720.
22. Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006 2;354:980-982.
23. Ozcan C, Wong SJ, Hari P. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006 2;354:980-982.
24. Allen JA, Adlakha A, Bergethon PR. Reversible Posterior leukoencephalopathy syndrome after bevacizumab/ FOLFIRI regimen for metastatic colon cancer. Arch Neurol 2006;63:1475-1478. (Pubitemid 44547561)
25. Kapiteijn E, Brand A, Kroep J, Gelderblom H. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome. Ann Oncol 2007;18:1745-1747. (Pubitemid 47506266)
26. Levy CF, Oo KZ, Fireman F, Pierre L, Bania MA, Sadanandan S, Yamashiro DJ, Bender JL. Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab. Pediatr Blood Cancer 2009;52:669-671
27. El Maalouf G, Mitry E, Lacout A, Lièvre A, Rougier P. Isolated brainstem involvement in posterior reversible leukoencephalopathy induced by bevacizumab. J Neurol 2008;255:295-296.
28. Koopman M, Muller EW, Punt CJ. Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: report of a case. Dis Colon Rectum 2008;51:1425-1426.
29. Govindarajan R, Adusumilli J, Baxter DL, El-Khoueiry A, Harik SI. Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006. J Clin Oncol 2006;24:e48.
30. Dogan E, Aksoy S, Arslan C, Dede DS, Altundag K. Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma.Med Oncol 2010 Dec;27:1436-1437.